2-166311552-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001365536.1(SCN9A):c.205G>A(p.Gly69Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,612,448 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001365536.1 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN9A | NM_001365536.1 | c.205G>A | p.Gly69Ser | missense_variant | Exon 2 of 27 | ENST00000642356.2 | NP_001352465.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN9A | ENST00000642356.2 | c.205G>A | p.Gly69Ser | missense_variant | Exon 2 of 27 | NM_001365536.1 | ENSP00000495601.1 | |||
| SCN9A | ENST00000303354.11 | c.205G>A | p.Gly69Ser | missense_variant | Exon 2 of 27 | 5 | ENSP00000304748.7 | |||
| SCN9A | ENST00000409672.5 | c.205G>A | p.Gly69Ser | missense_variant | Exon 2 of 27 | 5 | ENSP00000386306.1 | |||
| SCN9A | ENST00000645907.1 | c.205G>A | p.Gly69Ser | missense_variant | Exon 2 of 27 | ENSP00000495983.1 | ||||
| SCN9A | ENST00000454569.6 | c.205G>A | p.Gly69Ser | missense_variant | Exon 2 of 15 | 1 | ENSP00000413212.2 | |||
| SCN9A | ENST00000452182.2 | c.205G>A | p.Gly69Ser | missense_variant | Exon 3 of 11 | 1 | ENSP00000393141.2 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151356Hom.: 0 Cov.: 24 show subpopulations
GnomAD2 exomes AF: 0.0000521 AC: 13AN: 249550 AF XY: 0.0000591 show subpopulations
GnomAD4 exome AF: 0.000142 AC: 207AN: 1461092Hom.: 0 Cov.: 29 AF XY: 0.000140 AC XY: 102AN XY: 726900 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151356Hom.: 0 Cov.: 24 AF XY: 0.0000406 AC XY: 3AN XY: 73850 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Unlikely to be causative of SCN9A-related neuropathic pain syndromes (AD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 69 of the SCN9A protein (p.Gly69Ser). This variant is present in population databases (rs201243874, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with SCN9A-related conditions. ClinVar contains an entry for this variant (Variation ID: 538478). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SCN9A protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at